Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1964 Aug;39(206):403–405. doi: 10.1136/adc.39.206.403

Congenital Dopamine-secreting Neuroblastoma with Clinical and Biochemical Remission

E M Brett, T E Oppé, C R J Ruthven, M Sandler
PMCID: PMC2019329  PMID: 14206883

Full text

PDF
403

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BETTEX M., KASER H. Diagnostic and prognostic value of the determination of urinary output of vanillyl-mandelic acid in tumors of sympathetic nervous system. Arch Dis Child. 1962 Apr;37:138–141. doi: 10.1136/adc.37.192.138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. DARGEON H. W. Problems in the prognosis of neuroblastoma. Am J Roentgenol Radium Ther Nucl Med. 1960 Mar;83:551–555. [PubMed] [Google Scholar]
  3. GREENBERG R. E., GARDNER L. I. Catecholamine metabolism in a functional neural tumor. J Clin Invest. 1960 Nov;39:1729–1736. doi: 10.1172/JCI104195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. GROSS R. E., FARBER S., MARTIN L. W. Neuroblastoma sympatheticum; a study and report of 217 cases. Pediatrics. 1959 Jun;23(6):1179–1191. [PubMed] [Google Scholar]
  5. ISAACS H., MEDALIE M., POLITZER W. M. Noradrenaline-secreting neuroblastomata. Br Med J. 1959 Feb 14;1(5119):401–404. doi: 10.1136/bmj.1.5119.401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. KING R. L., STORAASLI J. P., BOLANDE R. P. Neuroblastoma: review of twenty-eight cases and presentation of two cases with metastases and long survival. Am J Roentgenol Radium Ther Nucl Med. 1961 Apr;85:733–747. [PubMed] [Google Scholar]
  7. KONTRAS S. B. Urinary excretion of 3-methoxy-4-hydroxymandelic acid in children with neuroblastoma. Cancer. 1962 Sep-Oct;15:978–986. doi: 10.1002/1097-0142(196209/10)15:5<978::aid-cncr2820150514>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  8. PISANO J. J., CROUT J. R., ABRAHAM D. Determination of 3-methoxy-4-hydroxymandelic acid in urine. Clin Chim Acta. 1962 Mar;7:285–291. doi: 10.1016/0009-8981(62)90022-0. [DOI] [PubMed] [Google Scholar]
  9. Potter E. L., Parrish J. M. Neuroblastoma, Ganglioneuroma and Fibroneuroma in a Stillborn Fetus. Am J Pathol. 1942 Jan;18(1):141–151. [PMC free article] [PubMed] [Google Scholar]
  10. ROSENSTEIN B. J., ENGELMAN K. DIARRHEA IN A CHILD WITH A CATECHOLAMINE-SECRETING GANGLIONEUROMA. CASE REPORT AND REVIEW OF THE LITERATUTE. J Pediatr. 1963 Aug;63:217–226. doi: 10.1016/s0022-3476(63)80332-7. [DOI] [PubMed] [Google Scholar]
  11. SOURKES T. L., DENTON R. L., MURPHY G. F., CHAVEZ B., SAINT CYR S. The excretion of dihydroxyphenylalanine, dopamine, and dihydroxyphenylacetic acid in neuroblastoma. Pediatrics. 1963 Apr;31:660–668. [PubMed] [Google Scholar]
  12. Smellie J. M., Sandler M. Secreting Intrathoracic Ganglioneuroma. Proc R Soc Med. 1961 Apr;54(4):327–329. [PMC free article] [PubMed] [Google Scholar]
  13. VON STUDNITZ W., KASER H., SJOERDSMA A. Spectrum of catechol amine biochemistry in patients with neuroblastoma. N Engl J Med. 1963 Aug 1;269:232–235. doi: 10.1056/NEJM196308012690503. [DOI] [PubMed] [Google Scholar]
  14. VOORHESS M. L., GARDNER L. I. Urinary excretion of norepinephrine, epinephrine and 3-methoxy-4-hydroxymandelic acid by children with neuroblastoma. J Clin Endocrinol Metab. 1961 Mar;21:321–335. doi: 10.1210/jcem-21-3-321. [DOI] [PubMed] [Google Scholar]
  15. WILLIAMS C. M., GREER M. Diagnosis of neuroblastoma by quantitative gas chromatographic analysis of urinary homovanillic and vanilmandelic acid. Clin Chim Acta. 1962 Nov;7:880–883. doi: 10.1016/0009-8981(62)90076-1. [DOI] [PubMed] [Google Scholar]
  16. YOUNG R. B., STEIKER D. D., BONGIOVANNI A. M., KOOP C. E., EBERLEIN W. R. Urinary vanilmandelic acid (VMA) excretion in children: use of a simple semiquantitative test. J Pediatr. 1963 Jun;62:844–854. doi: 10.1016/s0022-3476(63)80098-0. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES